These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34896122)
1. Comparisons of the immunological landscape of COVID-19 patients based on sex and disease severity by multi-omics analysis. Zhang T; Abdelrahman Z; Liu Q; Wang X; Chen Z Chem Biol Interact; 2022 Jan; 352():109777. PubMed ID: 34896122 [TBL] [Abstract][Full Text] [Related]
2. Sex- and age-specific clinical and immunological features of coronavirus disease 2019. Jin S; An H; Zhou T; Li T; Xie M; Chen S; Chen C; Ying B; Xu Z; Li X; Li M PLoS Pathog; 2021 Mar; 17(3):e1009420. PubMed ID: 33770147 [TBL] [Abstract][Full Text] [Related]
3. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517 [TBL] [Abstract][Full Text] [Related]
4. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124 [TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Immunity to Viral Infections. Jacobsen H; Klein SL Front Immunol; 2021; 12():720952. PubMed ID: 34531867 [TBL] [Abstract][Full Text] [Related]
6. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2. Agrawal S; Salazar J; Tran TM; Agrawal A Front Immunol; 2021; 12():739757. PubMed ID: 34745109 [TBL] [Abstract][Full Text] [Related]
7. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19. Hou Y; Zhou Y; Gack MU; Lathia JD; Kallianpur A; Mehra R; Chan TA; Jung JU; Jehi L; Eng C; Cheng F Signal Transduct Target Ther; 2021 Jul; 6(1):292. PubMed ID: 34330889 [TBL] [Abstract][Full Text] [Related]
8. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Rendeiro AF; Casano J; Vorkas CK; Singh H; Morales A; DeSimone RA; Ellsworth GB; Soave R; Kapadia SN; Saito K; Brown CD; Hsu J; Kyriakides C; Chiu S; Cappelli LV; Cacciapuoti MT; Tam W; Galluzzi L; Simonson PD; Elemento O; Salvatore M; Inghirami G Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33361110 [TBL] [Abstract][Full Text] [Related]
9. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Unterman A; Sumida TS; Nouri N; Yan X; Zhao AY; Gasque V; Schupp JC; Asashima H; Liu Y; Cosme C; Deng W; Chen M; Raredon MSB; Hoehn KB; Wang G; Wang Z; DeIuliis G; Ravindra NG; Li N; Castaldi C; Wong P; Fournier J; Bermejo S; Sharma L; Casanovas-Massana A; Vogels CBF; Wyllie AL; Grubaugh ND; Melillo A; Meng H; Stein Y; Minasyan M; Mohanty S; Ruff WE; Cohen I; Raddassi K; ; Niklason LE; Ko AI; Montgomery RR; Farhadian SF; Iwasaki A; Shaw AC; van Dijk D; Zhao H; Kleinstein SH; Hafler DA; Kaminski N; Dela Cruz CS Nat Commun; 2022 Jan; 13(1):440. PubMed ID: 35064122 [TBL] [Abstract][Full Text] [Related]
10. The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID. Noviello M; De Lorenzo R; Chimienti R; Maugeri N; De Lalla C; Siracusano G; Lorè NI; Rancoita PMV; Cugnata F; Tassi E; Dispinseri S; Abbati D; Beretta V; Ruggiero E; Manfredi F; Merolla A; Cantarelli E; Tresoldi C; Pastori C; Caccia R; Sironi F; Marzinotto I; Saliu F; Ghezzi S; Lampasona V; Vicenzi E; Cinque P; Manfredi AA; Scarlatti G; Dellabona P; Lopalco L; Di Serio C; Malnati M; Ciceri F; Rovere-Querini P; Bonini C Front Immunol; 2024; 15():1381091. PubMed ID: 39136010 [TBL] [Abstract][Full Text] [Related]
11. The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19. Xu G; Qi F; Wang H; Liu Y; Wang X; Zou R; Yuan J; Liao X; Liu Y; Zhang S; Zhang Z Front Immunol; 2021; 12():816745. PubMed ID: 35095917 [TBL] [Abstract][Full Text] [Related]
12. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity. Bolouri H; Speake C; Skibinski D; Long SA; Hocking AM; Campbell DJ; Hamerman JA; Malhotra U; Buckner JH; J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529167 [TBL] [Abstract][Full Text] [Related]
13. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. Lamadrid P; Alonso-Peña M; San Segundo D; Arias-Loste M; Crespo J; Lopez-Hoyos M Front Immunol; 2021; 12():651728. PubMed ID: 33859644 [TBL] [Abstract][Full Text] [Related]
14. Sex-based differences in severity and mortality in COVID-19. Alwani M; Yassin A; Al-Zoubi RM; Aboumarzouk OM; Nettleship J; Kelly D; Al-Qudimat AR; Shabsigh R Rev Med Virol; 2021 Nov; 31(6):e2223. PubMed ID: 33646622 [TBL] [Abstract][Full Text] [Related]
15. Sex-based clinical and immunological differences in COVID-19. Huang B; Cai Y; Li N; Li K; Wang Z; Li L; Wu L; Zhu M; Li J; Wang Z; Wu M; Li W; Wu W; Zhang L; Xia X; Wang S; Chen H; Wang Q BMC Infect Dis; 2021 Jul; 21(1):647. PubMed ID: 34225644 [TBL] [Abstract][Full Text] [Related]
16. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Koutsakos M; Rowntree LC; Hensen L; Chua BY; van de Sandt CE; Habel JR; Zhang W; Jia X; Kedzierski L; Ashhurst TM; Putri GH; Marsh-Wakefield F; Read MN; Edwards DN; Clemens EB; Wong CY; Mordant FL; Juno JA; Amanat F; Audsley J; Holmes NE; Gordon CL; Smibert OC; Trubiano JA; Hughes CM; Catton M; Denholm JT; Tong SYC; Doolan DL; Kotsimbos TC; Jackson DC; Krammer F; Godfrey DI; Chung AW; King NJC; Lewin SR; Wheatley AK; Kent SJ; Subbarao K; McMahon J; Thevarajan I; Nguyen THO; Cheng AC; Kedzierska K Cell Rep Med; 2021 Mar; 2(3):100208. PubMed ID: 33564749 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities. Lo Presti E; De Gaetano A; Pioggia G; Gangemi S Cells; 2022 Feb; 11(3):. PubMed ID: 35159352 [TBL] [Abstract][Full Text] [Related]
19. The effect of estrogen in coronavirus disease 2019. Ma Q; Hao ZW; Wang YF Am J Physiol Lung Cell Mol Physiol; 2021 Jul; 321(1):L219-L227. PubMed ID: 33949212 [TBL] [Abstract][Full Text] [Related]
20. Sex differences in immune responses that underlie COVID-19 disease outcomes. Takahashi T; Ellingson MK; Wong P; Israelow B; Lucas C; Klein J; Silva J; Mao T; Oh JE; Tokuyama M; Lu P; Venkataraman A; Park A; Liu F; Meir A; Sun J; Wang EY; Casanovas-Massana A; Wyllie AL; Vogels CBF; Earnest R; Lapidus S; Ott IM; Moore AJ; ; Shaw A; Fournier JB; Odio CD; Farhadian S; Dela Cruz C; Grubaugh ND; Schulz WL; Ring AM; Ko AI; Omer SB; Iwasaki A Nature; 2020 Dec; 588(7837):315-320. PubMed ID: 32846427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]